Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
information about tirzepatide These highlights do not include all the needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND® (tirzepatide) Injection, for subcutaneous useInitial U.S. Approval: 2022 Agonista del receptor GLP Amount:30MG Diet and Sports Nutrition
Agonista del receptor GLP 1: mecanismo de acción
Encounter note requirements The procedure note must document: the confirmed diagnosis and affected eye(s), the drug name and concentration (faricimab-svoa 6 mg/0.05 mL), the route of administration (intravitreal injection), the lot number and NDC of the vial used, and the wastage modifier justification (overfill volume discarded)
Diet and Sports Nutrition
Amount:30MG
Phase 3 ATTAIN-1 trial completed in 2025, showing ~10-12% weight loss at top dose
US$ 23.49
US$ 21.31
US$ 20.11
US$ 29.49
US$ 29.80
